# Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release

NDC: 42858-055
Generic name: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE
Labeler / Manufacturer: Rhodes Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20190822

FDA application: ANDA210651

## Active ingredients

- AMPHETAMINE ASPARTATE MONOHYDRATE: 1.25 mg/1
- AMPHETAMINE SULFATE: 1.25 mg/1
- DEXTROAMPHETAMINE SACCHARATE: 1.25 mg/1
- DEXTROAMPHETAMINE SULFATE: 1.25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42858-055"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42858-055
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=690e1ef4-caf7-4c48-a4ae-d2a0ab684e82